Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.75 USD | +8.02% | +6.21% | -5.91% |
Mar. 13 | Pulmatrix, Inc. Approves Termination of Margaret Wasilewski as Chief Medical Officer | CI |
Jan. 08 | Pulmatrix Explores Strategic Alternatives | CI |
Financials (USD)
Sales 2021 | 5.17M | Sales 2022 | 6.07M | Capitalization | 14.12M |
---|---|---|---|---|---|
Net income 2021 | -20M | Net income 2022 | -18M | EV / Sales 2021 | -5.21 x |
Net cash position 2021 | 51.55M | Net cash position 2022 | 34.77M | EV / Sales 2022 | -3.4 x |
P/E ratio 2021 |
-1.01
x | P/E ratio 2022 |
-0.71
x | Employees | 29 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 100% |
1 day | +8.02% | ||
1 week | +6.21% | ||
Current month | -12.06% | ||
1 month | -14.63% | ||
3 months | -7.80% | ||
6 months | -12.94% | ||
Current year | -5.91% |
Managers | Title | Age | Since |
---|---|---|---|
Teofilo Raad
CEO | Chief Executive Officer | 54 | 17-05-02 |
Peter Ludlum
DFI | Director of Finance/CFO | 68 | 22-04-17 |
Aidan Curran
CTO | Chief Tech/Sci/R&D Officer | - | 14-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Batycky
BRD | Director/Board Member | 56 | 19-10-31 |
Director/Board Member | 54 | 20-06-22 | |
Todd Bazemore
BRD | Director/Board Member | 53 | 20-09-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 1.75 | +8.02% | 38 380 |
24-03-27 | 1.62 | -4.18% | 11,761 |
24-03-26 | 1.691 | +1.24% | 4,676 |
24-03-25 | 1.67 | 0.00% | 7,597 |
24-03-22 | 1.67 | +1.83% | 3,013 |
Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-5.91% | 5.92M | |
+2.73% | 108B | |
+9.59% | 104B | |
+6.58% | 23.66B | |
-12.59% | 22.1B | |
-3.29% | 19.71B | |
-35.36% | 18.2B | |
-13.29% | 16.19B | |
+4.68% | 13.72B | |
+34.25% | 12.22B |